Variables Associated with HbA1c Improvement during CGM Therapy in Persons with T1D Treated with Multiple Daily Insulin Injections (MDI)

被引:0
|
作者
Ahlen, Elsa
Polonsky, William H.
Heise, Tim
Bolinder, Jan
Hirsch, Irl B.
Wedel, Hans
Hellman, Jarl
Olafsdottir, Arndis
Frid, Anders
Lind, Marcus
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
935-P
引用
收藏
页码:A241 / A241
页数:1
相关论文
共 50 条
  • [1] Impact of Continuous Glucose Monitoring (CGM) on Hypoglycemia in T1D Adults on Multiple Daily Insulin Injections (MDI)
    Olafsdottir, Arndis F.
    Hirsch, Irl B.
    Bolinder, Jan
    Heise, Tim
    Polonsky, William H.
    Dahlqvist, Sofia
    Frid, Anders
    Ahlen, Elsa
    Hellman, Jarl
    Wedel, Hans
    Lind, Marcus
    DIABETES, 2017, 66 : A240 - A240
  • [2] Variables associated with HbA1c and weight reductions when adding liraglutide to multiple daily insulin injections in persons with type 2 diabetes (MDI Liraglutide trial 3)
    Dahlqvist, Sofia
    Ahlen, Elsa
    Filipsson, Karin
    Gustafsson, Thomas
    Hirsch, Irl B.
    Tuomilehto, Jaakko
    Imberg, Henrik
    Ahren, Bo
    Attvall, Stig
    Lind, Marcus
    BMJ OPEN DIABETES RESEARCH & CARE, 2018, 6 (01)
  • [3] Early CGM Initiation Improves HbA1c in T1D Youth over the First 15 Months
    Prahalad, Priya
    Ding, Victoria
    Addala, Ananta
    New, Christin
    Conrad, Barry P.
    Chmielewski, Annette
    Geels, Elena
    Leverenz, Jeannine
    Martinez-Singh, Anjoli
    Sagan, Piper
    Senaldi, Julianne
    Freeman, Alex
    Scheinker, David
    Hood, Korey K.
    Desai, Manisha
    Maahs, David M.
    DIABETES, 2020, 69
  • [4] Sotagliflozin in Combination with Optimized Insulin Therapy Reduced HbA1c Levels with a Decreased Daily Insulin Requirement after 52 Weeks in Adults with T1D
    Pettus, Jeremy
    Weinzimer, Stuart A.
    Mccrimmon, Rory J.
    Blasco, Francisco Javier Ampudia
    Stewart, John A.
    Strumph, Paul
    Oliveira, Juliana H.
    Lapuerta, Pablo
    Castro, Rita
    DIABETES, 2018, 67
  • [5] Transition from Multiple Daily Injections (MDI) to Omnipod 5 Automated Insulin Delivery System Improves A1C in Type 1 Diabetes (T1D)
    Shah, Viral
    Criego, Amy B.
    Carlson, Anders L.
    Bhargava, Anuj
    Bode, Bruce W.
    Brown, Sue A.
    Forlenza, Gregory P.
    Levy, Carol J.
    Mehta, Sanjeev N.
    Laffel, Lori M.
    Aleppo, Grazia
    Buckingham, Bruce A.
    Desalvo, Daniel
    Hirsch, Irl B.
    Macleish, Sarah A.
    Pinsker, Jordan E.
    Ly, Trang T.
    DIABETES, 2021, 70
  • [6] Motivation and Attitudinal Assessment in Patients with T1D Using Multiple Daily Injections or Insulin Pump Therapy
    Alford, Jordin
    Koobatian, Maxwell
    Daigle, Ben
    Mathews, Kieron
    Dias, Louis
    DIABETES, 2019, 68
  • [7] Sustained Intensive Treatment and Long-Term Effects on A1C Reduction (SILVER Study) by CGM in Persons with T1D Treated with MDI
    Lind, Marcus
    Olafsdottir, Arndis F.
    Hirsch, Irl B.
    Bolinder, Jan
    Dahlqvist, Sofia
    Pivodic, Aldina
    Hellman, Jarl
    Wijkman, Magnus O.
    Schwarcz, Erik
    Albrektsson, Henrik
    Heise, Tim
    Polonsky, William
    DIABETES, 2020, 69
  • [8] Variables associated with insulin production in persons with type 2 diabetes treated with multiple daily insulin injections
    Westman, Klara
    Imberg, Henrik
    Albrektsson, Henrik
    Hirsch, Irl B.
    Tuomilehto, Jaakko
    Dahlqvist, Sofia
    Lind, Marcus
    PRIMARY CARE DIABETES, 2021, 15 (03) : 607 - 613
  • [9] Differences in Meeting Trimester-Specific HbA1c Goals in T1D Pregnancies Utilizing CGM vs. SMBG in a T1D Specialty Clinic
    Malecha, Emily
    Gao, Valerie
    Westfeldt, Elizabeth
    Snell-Bergeon, Janet K.
    Polsky, Sarit
    DIABETES, 2022, 71
  • [10] The use of continuous glucose monitoring (CGM) in a patient with longstanding type 1 diabetes (T1D) on multiple daily insulin injections and recurrent severe hypoglycaemia
    Fennell, D.
    Madden, A.
    McQuaid, S. E.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2022, 191 (SUPPL 4) : 107 - 107